INTRODUCTION
Anxiety disorders are common diseases with a lifetime prevalence of up to 25% (Kessler et al., 2005) . For the development of therapeutic avenues, it is of critical importance to identify the neural circuitries and mechanisms of neurotransmission mediating fear acquisition and, perhaps even more clinically important, fear subsidence. One established experimental paradigm to study these processes is Pavlovian fear conditioning, in which cues paired with aversive outcomes come to elicit typical fear responses and in which the organism learns to predict danger in their environment (LeDoux, 2000) . When conditioned cues no longer predict danger, as can be experimentally modeled through repetitive presentations of nonreinforced cues, fear responses decline: a behavioral phenomenon known as extinction (Maren and Quirk, 2004) . Substantial evidence indicates that extinction involves new learning that inhibits the expression of conditioned fear rather than erases the fear memory (Maren and Quirk, 2004; Bouton et al., 2006; Myers and Davis, 2007) . In fact, fear responses can spontaneously recover with the passage of time, be reinstated by the reinforcer alone, or be renewed in a context-dependent manner (Maren and Quirk, 2004) . This balance between fear memory consolidation and extinction has important clinical relevance in that it severely limits the beneficial outcomes of current treatments of anxiety disorders, such as panic and posttraumatic stress disorders. Studies in both animals (Paré et al., 2004; Maren and Quirk, 2004) and humans (Phelps and LeDoux, 2005) have indicated that interactions between the infralimbic region (IL) of the medial prefrontal cortex (mPFC) and the amygdala are critically involved in the consolidation of extinction learning. One intriguing possibility is that the IL exerts an inhibitory control over signal processing in amygdaloid circuits via GABAergic neuronal populations (Paré et al., 2004) . Two major populations of GABAergic neurons can be discerned in the amygdala: ''local'' GABAergic interneurons scattered in the local neuropil and paracapsular GABAergic intercalated cell masses. The paracapsular intercalated cell masses are organized in two clusters: one cluster (the lateral subdivision, lpara) is located along the external capsule, while a second cluster (the medial subdivision, mpara) is located at the border between the basolateral amygdaloid complex (BLA) and the central amygdaloid nucleus (CeA). The lpara neurons mostly enable feedforward control of signal flow from cortex to the BLA (Marowsky et al., 2005) , while the mpara neurons provide a feedforward inhibitory gate for signals between BLA and CeA and thereby between the major input and output station of the amygdala (Royer et al., 1999) . In particular, the GABAergic intercalated cells have been suggested to be prime candidates for mediating mPFC influences during extinction, although the case rests on indirect evidence only (as reviewed by Paré et al., 2004) . While formation of new memory represents the prevailing model of fear extinction, it does not rule out the possibility that multiple mechanisms underlie extinction of consolidated memory, as for instance, erasure of conditioned fear through synaptic depotentiation (Myers et al., 2006; Kim et al., 2007) . Of the various transmitter systems controlling synaptic interactions within the amygdala, the implication of endocannabinoids in extinction of conditioned fear has been well established (Marsicano et al., 2002; Lutz, 2007) , although information about the neuronal targets and synaptic network mechanisms mediating the fear-alleviating effects is sparse to date.
In this respect, it is of particular interest to note that mRNA for receptors of neuropeptide S (NPS), a recently discovered transmitter with anxiolytic-like effects, displays a specific expression pattern within the rat amygdala, with high levels occurring in and around the intercalated cell masses (Xu et al., 2007) . NPS is a neuropeptide consisting of 20 amino acids with serine as the amino-terminal residue (Xu et al., 2004) , is highly conserved in different vertebrate species, including humans (Reinscheid, 2007) , originates from a cluster of cells in the brainstem between the locus coeruleus and Barrington's nucleus, and produces robust anxiolytic effects when administered intracerebroventricularly to mice in various tests of generalized anxiety (Xu et al., 2004) .
These findings prompted us to examine the mechanisms of action of NPS in the amygdala in relation to anxious behavior, fear acquisition, and extinction. We have combined behavioral studies in mice and electrophysiological in vitro experiments in amygdala slice preparations making use of GAD67-EGFP knockin mice, a transgenic mouse strain, in which EGFP was used as a reporter gene to tag GAD67-expressing neurons (Tamamaki et al., 2003) . The data demonstrate that endogenous NPS in the amygdala acts to reduce general anxiety and to facilitate the extinction of conditioned fear responses through mechanisms involving a subpopulation of intercalated GABAergic neurons in the amygdala and thereby pave the way for novel pharmacological avenues in the control of fear acquisition and extinction.
RESULTS

Anxiolytic-like Effects of NPS in the Amygdala
The first series of experiments aimed at identifying the effects of NPS in the amygdala on anxious behavior. NPS was locally infused in small volumes bilaterally in the amygdala, with histologically verified injection sites centered in the lateral amygdala (LA) and basolateral (BLA) amygdaloid complex ( Figure S1 available online). Anxiety was tested 20 min after termination of NPS application via the open field and elevated plus maze test. Data are illustrated in Figure 1 . NPS-treated mice displayed a reduction in anxious behavior in both the open field test (n = 9; Figure 1A ) and the elevated plus maze (n = 7; Figure 1B ) when compared to saline-injected controls (n = 6 for each test), as evidenced by the significant increase in visits and distances covered in the center and the significant increase and decrease in time spent on open and closed arms, respectively. In order to investigate the possible involvement of endogenous NPS in anxiety behavior, the NPS receptor antagonist SHA 68 (Okamura et al., 2008) was locally injected into the amygdala, using protocols as for NPS. Compared to vehicle-injected controls (Cremophor-PBS; n = 6), SHA 68 produced a significant anxiogenic response in mice tested in the open field (n = 6; Figure 1A ). Importantly, locomotor activity and distance covered at the border were not different between the different pharmacological groups, and Cremophor-PBS controls did not differ in any of the tested behaviors from saline-injected controls. In separate groups of animals, the time course of the effect of NPS on general anxiety was tested in the elevated plus maze. The anxiolytic responses were significant 20 min after application of NPS (n = 7), while behavioral activity had returned to control level within 2 hr (n = 4) and 4 hr (n = 4) thereafter ( Figure S3 ). Total locomotor activities were not significantly different between groups at any time. Finally, NPS-treated animals displayed anxiolytic-like behavior in the dark-light test ( Figure S4 ). Overall, these results provide evidence that endogenous NPS in the amygdala, more specifically in the LA/BLA region, induces a reduction in general anxiety, thereby separating anxiolytic from hyperlocomotor effects that have been observed after intracerebroventricular injections (Xu et al., 2004) .
NPS in the Amygdala Facilitates Extinction of Conditioned Fear
The effects of NPS in the amygdala on conditioned fear and extinction were investigated next. Mice were fear conditioned in an auditory fear conditioning paradigm, and responses to the conditioned (CS+) and neutral (CSÀ) tone were determined to assess fear memory. The conditioned response generally took a graduated development of different behavioral components, and in accordance with previous observations (Laxmi et al., 2003) , we considered freezing as one adequate behavioral response indicating fear in different test situations. Twenty-four hours after fear training, retrieval of conditioned fear was analyzed (R1), followed by fear extinction training through successive presentation of the nonreinforced cues during five retrieval sessions (R2-R6). Twenty-four hours later, extinction recall was tested in two successive sessions (E1, E2), followed by renewal of conditioned fear through exposure to the conditioning context (RN). NPS was injected at different time points during the fear training protocol in order to distinguish between effects on fear acquisition and extinction. NPS-treated animals were compared with controls that had received saline injections at matching time points. Freezing responses upon CS+ presentation were statistically analyzed using the Mann-Whitney U test for single test session (R1-R6, E1, E2, RN, compared to saline controls) and the Wilcoxon test for within-group differences between the test sessions. Data are illustrated in Figure 2 . Saline controls (n = 15, in two different groups) displayed a high level of conditioned freezing responses upon CS+ presentation during the first retrieval session (R1) and a continuous decline during nonreinforced CS+ exposure during subsequent retrieval sessions (R2-R6), indicating fear extinction (Figures 2A and 2B , dashed line). Differences to R1 (Wilcoxon test) became significant at R4 in the different groups and persisted throughout extinction training (p < 0.05). Consolidation of extinction was observed during recall 24 hr later (E1, E2) (p < 0.05), and re-exposure to the conditioning context resulted in a significant increase in freezing responses to CS+ compared to E2 (p < 0.05), indicating renewal of fear memory (RN). Next, fear training was performed 20 min after local infusion of NPS bilaterally into the LA/BLA, at times coinciding with anxiolytic-like effects of the drug. Conditioned fear responses, fear extinction, extinction recall, and renewal of fear memory were undistinguishable from those observed in salineinjected control animals (n = 6 each group; Figure 2A) . A similar lack of effect of NPS was observed upon application 1 hr after training during a period of fear memory consolidation (n = 3; data not shown). When NPS was injected 2 hr before fear memory retrieval ( Figure 2B , n = 7), animals displayed unaltered freezing responses to CS+ presentations during the first retrieval session (R1) but an acceleration of fear extinction compared to controls (n = 6) upon presentation of the nonreinforced cues during subsequent retrieval sessions with significantly reduced freezing at R3 (p < 0.05). Application of NPS 20 min prior to R1 resulted in a significant reduction in freezing responses at R1 (p < 0.05), R2 (p < 0.05), R3 (p < 0.01), and the acute anxiolytic-like action could not be discerned from effects on fear extinction (n = 6; data not shown). A facilitatory effect of NPS on fear extinction became evident during extinction recall, where NPS-treated animals displayed significantly reduced freezing responses compared to saline-treated controls (E1 and E2; p < 0.05), while re-exposure to the conditioning context resulted in a renewed fear response with no differences between groups of animals. Finally, application of NPS after extinction training (20 min post R6; n = 5, data not shown) had no significant effect on extinction recall nor renewal of conditioned fear responses. Freezing in response to CSÀ presentation was at a low level at the various retrieval sessions in all groups (see Laxmi et al., 2003) , and a significant effect of NPS was not observed.
In order to investigate the possible involvement of endogenous NPS in the amygdala in conditioned fear responses, we locally injected the NPS receptor antagonist SHA 68 (Okamura et al., 2008) into the LA/BLA region at times that had been proven relevant with respect to NPS action. Upon injection of SHA 68 at 2 hr before fear memory retrieval ( Figure 2B , filled circles, n = 7), animals displayed high freezing responses to CS+ presentations throughout extinction training, with significant differences compared to vehicle-injected controls from R4 to E2 (Mann-Whitney U test; p < 0.05). Mice injected with the solvent Cremophor-PBS at 2 hr before R1 (n = 3) showed undistinguishable freezing responses from those in saline-injected controls (data not shown). Noteworthy, conditioned fear behavior and extinction were undistinguishable in the three saline-injected groups at the three different time points (20 min prior to fear training, 20 min and 2 hr prior to R1; n = 20 total) and the Cremophor-PBS-injected controls (n = 3). Behavioral experiments in the Behavioral data were obtained 20 min after bilateral injection of NPS (0.5 ml, 10 mM), SHA 68 (0.5 ml, 10 mM), NaCl and Cremophor-PBS buffer, respectively. Values are mean ± SEM; * and **, significantly different from the control group (p < 0.05 and p < 0.01, respectively). different pharmacological groups were performed largely in parallel and included mates of the same litters, thereby minimizing the impact of uncontrolled variables.
NPS Enhances Synaptic Transmission at Glutamatergic Synapses on Paracapsular GABAergic Cells
The next series of experiments aimed at identifying the mechanisms of action of NPS in the synaptic network of the LA/BLA complex and paracapsular GABAergic intercalated cells, based upon our behavioral data and the high expression level of NPS receptors in that area of the amygdala (Xu et al., 2007) . In slice preparations of the amygdala from GAD67-EGFP mice (Tamamaki et al., 2003) , whole-cell recordings were obtained from LA principal neurons (LA PN) and paracapsular GABAergic intercalated cells (para IN). The paracapsular GABAergic intercalated cells were readily discernible in coronal slices as clusters of densely packed EGFP-labeled cells located at the lateral border of the LA along the external capsule (lateral cluster, lpara) and at medial sites facing the CeA (medial cluster, mpara; Figure S5 ). Furthermore, scattered EGFP-labeled neurons were present within the LA, most likely representing local GABAergic interneurons (LA IN; Figure S5 ). The different neuronal cell types were separated by their electrophysiological properties in currentclamp recordings ( Figure S5 ).
Next, glutamatergic synaptic transmission was evoked in mpara IN by extracellular stimulation within the LA in the presence of 100 mM picrotoxin and 50 mM AP5. Bath application of NPS (10 mM) resulted in an enhancement of glutamate receptor-mediated EPSCs, as illustrated by the representative traces in Figure 3A . The mean amplitudes of EPSCs in para IN were significantly increased from À30 ± 4 pA to À74 ± 14 pA (n = 13) after NPS application ( Figure 3B ; n = 13; p < 0.01) in slices obtained from mice at postnatal ages P15-26. In slices from mice of the same developmental state (P47-56) as in behavioral testing, NPS application similarly increased the mean amplitudes of evoked EPSCs in mpara IN from À43 ± 8 pA to À96 ± 19 pA (Figure 3B ; n = 12; p < 0.01). The effect of NPS was near maximal at concentrations 10-50 mM ( Figure S6 ). Previous addition of the NPS receptor antagonist SHA 68 (100 mM; Okamura et al., 2008) abolished responses to NPS in all tested neurons (n = 5; Figure 3A ). Plotting the averaged amplitudes, normalized to the mean amplitude of the EPSCs during baseline stimulation, against time demonstrated a gradual increase of the postsynaptic responses after NPS application ( Figure 3A ). On average, the maximal change of EPSC amplitudes in the presence of NPS was 262% ± 62% and 220% ± 21% at P15-26 and P47-56, respectively. The membrane input resistance was not significantly altered by NPS (477 ± 30 MU at baseline, 502 ± 25 MU in NPS, n = 26, p > 0.5; data not shown). The EPSC amplitudes stayed constant during control stimulation (À32 ± 7 pA at baseline and À32 ± 3 pA at the end of the experiment; change 100% ± 5% of baseline; n = 3, P15-26; À50 ± 7 pA at baseline and À44 ± 6 pA at the end of the experiment; 82% ± 7%; n = 6, P47-56) and in the presence of the NPS receptor antagonist SHA 68 (À29 ± 7 pA at baseline and À30 ± 1 pA after NPS application; change 108% ± 5%; n = 5; P15-26). The EPSCs were maximally increased within 20-40 min after application of NPS and upon washout returned to near-control values within 70-80 min ( Figure 3C ; n = 12; P47-56). Mean amplitudes were significantly increased by NPS application from À43 ± 8 pA at baseline to À96 ± 19 pA during maximal NPS action and gradually declined to À68 ± 9 pA during washout ( Figure 3D ). The relative change of the EPSC amplitudes was significantly reduced after washout (144% ± 11%, n = 9) compared to the maximal change (220% ± 21%, n = 12; p < 0.05). Furthermore, in the same types of mpara IN, GABA A receptor-mediated IPSCs were recorded in the presence of DNQX and AP5, and the effects of NPS were tested ( Figure S6 ). Plotting the normalized amplitudes of the IPSCs revealed no change in responses after NPS application compared to baseline stimulation. The mean amplitudes did not differ significantly (À56 ± 6 pA during baseline stimulation and À62 ± 8 pA after NPS; n = 5; Figure S6 ). In addition, the effects of NPS on paired-pulse facilitation were examined. Paired-pulse facilitation refers to an increase in a second synaptic response in a doublestimulation protocol, relating to a presynaptically mediated increase in transmitter release. EPSCs in mpara IN were recorded upon intra LA stimulation with a paired-pulse interval of 100 ms in slices from P47-56 mice. EPSCs showed robust paired-pulse facilitation of 1.4 ± 0.1 (À52 ± 7 pA for the first response and À63 ± 5 pA for the second response; n = 11; Figures 3E and 3F). Application of 10 mM NPS significantly (p < 0.05) reduced the paired-pulse ratio to 0.89 ± 0.1 (À124 ± 25 pA for the first response and À102 ± 21 pA for the second response; n = 11; Figures 3E and 3F) . During presence of NPS, the EPSC amplitude of the first response was significantly increased compared to baseline stimulation (p < 0.05). Finally, intrinsic electrotonic or electrogenic properties of LA PN were not different before or in the presence of NPS (Supplemental Data).
Effects of NPS on glutamatergic synaptic responses in the other major types of neurons in this region of the amygdala, Averages of relative freezing duration upon CS+ presentation during retrieval sessions (R1-R6), extinction (E1, E1), and renewal (RN). Diagrams represent effect of bilateral injections into LA/ BLA of (A) NPS and NaCl 20 min before training, and (B) NPS, SHA 68 and NaCl two hours before retrieval session 1. Data are mean ± SEM. Asterisks indicate differences in freezing in a respective session after administration of NPS or SHA 68 compared to saline (*, p < 0.05; **, p < 0.01).
principal neurons (LA PN) and local interneurons (LA IN), were investigated next. The stimulation protocol and placement of the stimulation electrodes were as described before. Neither for LA PN nor for LA IN could an NPS-induced increase of EPSCs be detected, as illustrated by representative current traces and plots of normalized amplitudes ( Figures 4A and 4B ). The EPSC amplitudes were not significantly different before or in the presence of NPS compared to baseline values (À60 ± 10 pA during baseline stimulation and À72 ± 12 pA after NPS application, n = 6 for LA PN; À66 ± 18 pA during baseline stimulation and À89 ± 31 pA after NPS application, n = 8 for LA IN; Figures 4C  and 4D ). The relative changes of the EPSC amplitudes in LA PN were 113% ± 8% and in LA IN 128% ± 13% (n = 6 and n = 8, respectively; Figure 4E ). The observed changes in LA PN and LA IN were significantly smaller than those detected in mpara IN (p < 0.01).
These data suggest that NPS positively modulates transmission at glutamatergic but not at GABAergic synapses on mpara IN. Furthermore, glutamatergic synapses projecting on principal neurons or local interneurons within the LA seem to be unaffected. One caveat of the electrical stimulation is that polysynaptic components might contaminate glutamatergic EPSCs in the different types of neurons. Polysynaptic responses were particularly evident in lpara IN, which led us to exclude these types of 
. Target-Specific Effect of NPS on Evoked EPSCs
(A) Representative current traces of glutamate receptor-mediated EPSCs in mpara IN (in P15-26 animals, n = 13) show an increase in EPSC amplitude in the presence of NPS at 10 mM (b, gray) compared to baseline stimulation (a, black), which is blocked by the NPS receptor antagonist SHA 68 (100 mM). Example traces refer to the time-points (a, b) depicted in the normalized amplitude-plot. At times of near-maximal NPS action, the mean EPSC amplitudes are significantly increased compared to pre-application baseline (B; p < 0.01), whereas amplitudes remain unchanged with no added NPS or in the presence of both NPS and receptor antagonist (see text for further details). (C) Representative current traces of glutamate receptor-mediated EPSCs in mpara IN (in P47-56 animals, n = 12) and normalized amplitudes during baseline stimulation (a), maximal NPS effect (b) and $70 min after NPS application (c, wash-out) show a time-dependent decline of the NPS induced effects on evoked EPSCs. (D) Changes of the mean amplitudes compared to baseline amplitudes during full NPS effect (NPS versus baseline p < 0.01) and after $70 min of wash-out (wash-out versus baseline p < 0.05). Comparison of the relative increase of EPSC-amplitudes at time points b and c revealed a significant reduction after wash-out (F; p < 0.05). (E) Effects of NPS on paired-pulse facilitation of EPSCs evoked upon intra LA stimulation in mpara IN. Representative current traces of paired-pulse experiments with a paired-pulse interval of 100 ms before (black) and during presence of 10 mM NPS (gray). During NPS, only the first response increased significantly (p < 0.05), and the paired pulse ratio was significantly reduced (p < 0.05; F). Data are mean ± SEM.
neurons from the foregoing analysis. Therefore, in the next experimental line, stimulation strength was reduced to evoke putative monosynaptic responses in the major types of neurons and investigate the effects of NPS. Stimulation electrodes were positioned within the LA for recording EPSCs in LA IN and in the external capsule for recording EPSCs in lpara IN; in view of the synaptic input to mpara IN from both cortical fibers and LA/BLA, stimulation electrodes were positioned in the external capsule and the LA neuropil in two series of experiments (Szinyei et al., 2000; Marowsky et al., 2005; Geracitano et al., 2007) . The monosynaptic nature of evoked responses were indicated by high failure rates (55% ± 4%, n = 18; 13% ± 7%, n = 5; 23% ± 4%, n = 13; for mpara IN, LA IN and lpara IN, respectively; and 22% ± 5%, n = 7 for mpara IN during EC-stimulation, see Figure 5 ), constant latencies (3.5 ± 0.2 ms, n = 18; 3.7 ± 0.2 ms, n = 5; 4.2 ± 0.3 ms, n = 13; for mpara IN, LA IN and lpara IN, respectively; and 4.6 ± 0.5 ms, n = 7; for mpara IN during EC stimulation), and typical rise times (10%-90%) (0.9 ± 0.1 ms, n = 10; 0.9 ± 0.2 ms, n = 5; and 1.0 ± 0.1 ms, n = 18; for lpara IN, LA IN and mpara IN, respectively; and 1.1 ± 0.3 ms, n = 7; for mpara IN during EC stimulation). Therefore, the EPSCs are referred to as monosynaptic in the following. In mpara IN, NPS modulated monosynaptic EPSCs evoked upon stimulation of the local LA neuropil but left cortically evoked EPSCs unaltered. During presence of NPS, EPSC-success amplitudes upon stimulation of the local LA neuropil showed only a slight, not significant increase (À16 ± 2 pA during baseline stimulation and À20 ± 2 pA after NPS application, n = 18; Figure 5A ). In the same neurons, NPS reduced the failure rates significantly (25% ± 5%) compared to baseline (control: 55% ± 4%, n = 18; p < 0.01; Figure 5A ). By contrast, monosynaptic EPSCs upon stimulation of the external capsule in mpara IN (n = 7; Figure 5D ) were not changed after addition of NPS in terms of amplitude (À17 ± 4 pA versus À14 ± 2 pA) and failure rates (22% ± 5% versus 28% ± 8%). Furthermore, NPS was not found to modify properties of monosynaptic EPSCs in LA IN or lpara IN. In LA IN (Figure 5B ), neither EPSC-success amplitudes (À26 ± 10 pA and À28 ± 8 pA for baseline stimulation and during NPS, respectively; n = 5) nor failure rates (13% ± 7% and 10% ± 6%) changed significantly. In lpara IN (Figure 5C ), amplitudes of EPSCs amounted to À24 ± 3 pA during baseline stimulation and nonsignificantly increased to À33 ± 5 pA after NPS application (n = 13). Failure rates remained unaltered in the presence of NPS compared to baseline (23% ± 4% and 195 ± 3%, respectively; n = 13). These data confirmed the specific effect of NPS on glutamatergic synaptic transmission to mpara IN within the amygdala. Furthermore, the reduction in failure rate hinted at a presynaptic location of the mediating receptors.
NPS Modulates Glutamatergic Transmission to Paracapsular GABAergic Neurons through Receptors Located in Presynaptic Principal Neurons
In order to distinguish between pre-and postsynaptic mechanisms underlying the observed NPS-mediated increase in glutamatergic EPSCs, spontaneous miniature EPSCs (mEPSCs) were recorded in mpara IN, LA PN, and lpara IN in the presence of TTX. Results are illustrated in Figure 6 . Analyses of the recorded mEPSCs revealed no significant changes of mEPSC amplitudes after NPS application compared to control traces in mpara IN (À19 ± 1 pA in baseline recordings and À18 ± 1 pA after NPS; data averaged from observations in n = 18 cells), LA PN (À18 ± 1 pA in baseline recordings and À18 ± 1 pA after NPS, n = 18), and lpara IN (À21 ± 1 pA in baseline recordings and À19 ± 0.8 pA after NPS, n = 14) ( Figures 6A and 6B) . By comparison, the frequency of mEPSCs in mpara IN increased upon NPS application from 1.4 ± 0.3 Hz during baseline recordings to 2.6 ± 0.6 Hz after NPS (n = 18; Figure 6C ). In LA PN and lpara IN, mEPSCs were not significantly different before or during NPS action (for LA IN 1.2 ± 0.4 Hz baseline, 1.3 ± 0.5 Hz after NPS; n = 18; for lpara IN 2.9 ± 1 Hz baseline and 2.9 ± 1 Hz NPS, n = 14; Figure 6C) . Because of variations in frequencies between individual recordings, the relative increase of mEPSC frequencies was calculated ( Figure 6D ). NPS significantly increased mEPSC frequencies in mpara IN to 170% ± 13% of baseline frequencies (p < 0.01) compared to unaltered frequencies in LA PN (117% ± 12%) and lpara IN (99% ± 3%). Furthermore, high-pressure somatic application of 200 mM glutamate in ACSF (in the presence of 100 mM picrotoxin, 50 mM AP5, and 1 mM TTX) to mpara IN evoked robust excitatory responses (À153 ± 32 pA; n = 12), which showed no significant change after NPS application (À176 ± 51 pA, n = 12; 118% ± 16% of baseline; Figure S6 ) compared to controls. Similar results were obtained in LA PN, in which responses to exogenous glutamate were not modulated through NPS (À107 ± 17 pA to À115 ± 24 pA; 119% ± 24% of baseline; n = 10, Figure S6 ). These findings support the notion that NPS acts via a mechanism that resides on glutamatergic terminals presynaptic to mpara IN.
Determination of the exact cellular location of the mediating receptors is hampered by the lack of specific antibodies against the NPS receptor. High densities of neurons expressing NPSR mRNA were observed in the LA and BLA subdivisions of the amygdala, while only scattered signals were found in medial, basomedial, and anterior cortical amygdaloid nuclei ( Figures 7A and  7B ). Notably and in contrast to the rat brain, no expression of NPSR was detected in intercalated amygdaloid nuclei of the mouse. In order to obtain more detailed information on NPSR expression sites in amygdaloid neurons, we used two alternative approaches. In one, NPSR mRNA was detected in single neurons, which had been classified as mpara IN, lpara IN, or LA PN based upon morphological and electrophysiological criteria, Figure 7C ). Results presented thus far allow for a working hypothesis that NPS receptors are expressed in LA PN, activation of which results in an increase in glutamatergic synaptic transmission to mpara IN. The GABAergic neurons of the mpara cell masses have been found to project to the CeA (Paré and Smith, 1993) and to be contacted by axon collaterals of principal neurons in LA/BLA, thereby gating impulse traffic from cortical inputs via LA/BLA to the principal output neurons in the CeA (Royer et al., 1999; Paré et al., 2003) . If NPS receptors are located at glutamatergic connections from LA PN to mpara, and activation of these receptors induces an increase in glutamatergic excitation, it can be expected that NPS leads to an increase in both monosynaptic excitatory responses in mpara and disynaptic inhibitory responses in CeA principal neurons (PN), while monosynaptic responses in CeA should not or to a lesser degree be modulated ( Figure 8A ). In a further attempt to identify the anatomical site of NPS receptor modulation within this circuit, we experimentally tested this hypothesis. Wholecell recordings were performed at a holding potential of À50 mV in principal neurones of the CeA next to the medial paracapsular intercalated GABAergic clusters. Local stimulation within the LA gave rise to biphasic postsynaptic responses (monosynaptic EPSCs inwardly directed, and disynaptic IPSCs outwardly directed) in CeA PN ( Figure 8B ). Both current components of the biphasic response could be blocked by the addition of DNQX (n = 4), verifying the disynaptic nature of the IPSC ( Figure 8C ). EPSC and IPSC amplitudes were monitored during 120 stimulation pulses (interstimulus interval 20 s) and were normalized to the first 20 baseline responses. Bath application of NPS significantly increased the amplitudes of the inhibitory response component, shifting the mean amplitudes from 35 ± 6 pA during baseline stimulation to 94 ± 15 pA (p < 0.01; n = 17; P15-26) during near-maximal action of NPS, whereas the monosynaptic EPSC component was only slightly reduced from À52 ± 12 pA to À42 ± 13 pA in the same neurons ( Figure 8D ). The presence of NPS significantly increased the IPSC amplitudes to 282% ± 62% (p < 0.01), whereas EPSC amplitudes were not affected (80% ± 8% of control values; Figure 8E ). Effects of NPS in neurons at P15-26 were not different from those at P47-56 ( Figures 8D and 8E) , in that the mean IPSC amplitudes were significantly increased from 35 ± 5 pA during baseline stimulation to 71 ± 13 pA (relative change of 209% ± 25%; n = 7; P47-56) after NPS application, whereas the mean amplitudes of the EPSCs was unaffected (À93 ± 30 pA baseline and À98 ± 28 pA NPS; 122% ± 15%; n = 7; Figures 8D and 8E ).
DISCUSSION
The present study aimed at identifying the mechanisms of action of NPS in neuronal circuits of the mouse amygdala in relation to anxious behavior, conditioned fear, and fear extinction. Three main findings were obtained. First, local injection of NPS into the basolateral amygdaloid complex resulted in an anxiolyticlike effect, reflected by an acute reduction in general anxiety and an accelerated extinction of conditioned fear, while injection of the NPS receptor antagonist SHA 68 exerted functionally opposing effects. Second, NPS increased glutamatergic synaptic transmission to intercalated GABAergic neurons of the medial paracapsular cluster through a presynaptic effect mostly involving principal neurons in the LA. Third, NPS receptors were shown to be densely expressed in the mouse BLA complex and, at the single-cell level, in LA principal neurons but not paracapsular GABAergic neurons. The following discussion examines the possibility that these effects are functionally interrelated.
Sites of NPS Modulation in Neuronal
Circuits of the Amygdala By virtue of their location, paracapsular intercalated cells are ideally suited to control signal flow in the amygdala in a feedforward inhibitory manner. While neurons in both lpara and mpara clusters share a GABAergic nature and are densely innervated by excitatory cortical input fibers (reviewed by Paré et al., 2004 ), they contact different major targets in the amygdaloid neuronal network. Neurons in the lpara cluster project to the BLA complex and generate feedforward IPSPs in BLA principal neurons (Marowsky et al., 2005) , while mpara neurons are connected to mediate topographically organized feedforward inhibition to principal neurons in the CeA nucleus (Royer et al., 1999) . Furthermore, stimulation of the BLA complex evokes short-latency EPSPs in mpara neurons, indicating monosynaptic input from the respective principal neurons (Royer et al., 1999) . Another population of GABAergic neurons is represented by local interneurons, comprising around 25% of the neuronal population, which also receive excitatory cortical inputs and mediate feedforward (and feedback) inhibition to the principal neurons within the local neuropil (Szinyei et al., 2000) . We have shown in the present study that stimulation of NPS receptors resulted in an increase in glutamatergic synaptic transmission to paracapsular intercalated neurons. The following line of evidence suggests that synaptic connections between LA principal neurons and (5) Upon paired stimulation within the LA, NPS increases the amplitude of EPSCs in mpara IN in response to the first stimulus and decreases the paired-pulse ratio, indicating an NPS-mediated increase in initially low release probability (Debanne et al., 1996) . (6) Semiquantitative PCR from single, physiologically identified types of neurons shows that NPS receptors are expressed in LA principal neurons, but not in mpara or lpara interneurons. Target-specific modulation of presynaptic release has been described in various brain regions, including glutamatergic transmission to subsets of GABAergic neurons (Ferraguti et al., 2005) . The mechanisms underlying the target specific action of NPS in the amygdala observed in the present study remain unknown but may relate to various subtypes of LA/BLA principal neurons (Sosulina et al., 2006) or synapse-specific expression of NPSR, as has recently been reported for presynaptic NMDA receptors in rat somatosensory cortex (Brasier and Feldman, 2008) . It is important to note that different sites of stimulation were used in the present study in order to activate the major glutamatergic synaptic connections to the different types of neurons of interest. This approach allows us to draw conclusions on their involvement in NPS modulation, but does not, of course, provide an exclusive or complete profile. For instance, microstimulation within the LA may have activated cortical fibers en passant, adding to the recorded EPSCs in mpara IN. However, no NPS receptor expression has been observed in the mouse infralimbic prefrontal cortex by in situ hybridization (Y.-L.X. and R.K.R., unpublished data), thereby voting against the possibility that the major cortical input relating to fear extinction is involved in NPS action. Taken together, available data strongly suggest that NPS mediates an increase in glutamatergic synaptic transmission to mpara IN through NPS receptors located at presynaptic sites in connected principal neurons in the LA. While this scenario is not an exclusive or complete one, it nevertheless represents the most parsimonious interpretation of our data from single-cell electrophysiological, RNA expression, and anatomical experiments.
Action of NPS in Amygdaloid Circuits in Relation to Fear Behavior
The behavioral consequences of NPS in the amygdala were investigated in the present study through bilateral application of NPS and the NPS receptor antagonist SHA 68 aimed at the basolateral amygdaloid complex. The exact distribution of the drug could not be assessed under the present experimental conditions, but the locality of the injection site in LA/BLA and the restricted diffusion of NPS were verified through histological reconstruction of the position of the needle injector tip and fluorescently labeled Cy3-NPS, respectively. NPS, under these conditions, exerted anxiolytic-like effects in three different tests of anxiety, namely the open field, the elevated plus maze, and the dark-light test, which were not associated with an increase in locomotor activity and thereby differed from results obtained after intracerebroventricular application of NPS (Xu et al., 2004) . These findings support the notion that NPS affected a local neuronal network in the present study and limit the possibility that arousal-like effects (Xu et al., 2004) confounded the interpretation of the behavioral data. The anxiolytic effects of NPS were observed within 20 min after application, and fully declined after 2 hr, indicating an acute effect on the expression of fear. It is important to note that a similar time course of action was also observed with respect to arousal-like hyperlocomotion after intracerebroventricular application of NPS (Xu et al., 2004) and with respect to the increase in glutamatergic transmission to mpara IN in vitro (present study). That endogenous NPS in the amygdala is involved in fear behavior is indicated by the anxiogenic-like effect obtained upon application of the NPS receptor antagonist SHA 68.
Another series of experiments sought to determine whether NPS is involved in the acquisition or extinction of fear memory by delivering NPS at defined time points in relation to training or testing in a Pavlovian fear conditioning paradigm. To distinguish between possible effects on acquisition and expression of fear, two groups of animals received NPS immediately (20 min) before fear training or immediately (20 min) before testing conditioned responses to the CS during retrieval sessions 24 hr after training. Pretraining application of NPS had no effect on conditioned fear responses as compared to vehicle-injected controls, whereas pretesting application resulted in a decrease in conditioned fear responses, indicating an influence of NPS on fear expression rather than fear learning. The finding that NPS applied 1 hr after training yielded conditioned fear responses indistinguishable from controls is in line with these conclusions. Furthermore, the lack of effect of NPS upon both pre-and posttraining injections on conditioned fear responses is suggestive of a lack of influence on fear memory consolidation. It should be kept in mind, however, that the results in the present study were obtained upon local injection of NPS into the BLA complex and the use of auditory cued fear conditioning paradigms. Additional studies involving other forms of fear memory and extended neuronal circuits, as for instance, contextual fear and hippocampal networks (see Maren and Quirk, 2004) , are needed to unravel additional potential sites and mechanisms of NPS influence on conditioned fear behavior. One consistent observation made in the present study was that application of NPS immediately (20 min) before the first retrieval session resulted in decreased fear responses throughout successive retrieval trials used for extinction training. In addition, tests of consolidated extinction performed 24 hr after extinction learning revealed reduced fear responsiveness. To further distinguish between effects on expression of fear versus extinction of fear, NPS was applied 2 hr before the first retrieval session. Conditioned fear responses during the first retrieval trial were not significantly different from control, while extinction learning followed a faster time course compared to controls. Application of the NPS receptor antagonist SHA 68 at the same time point before retrieval had no significant effect on the expression of the first conditioned response, but resulted in a significant impairment of extinction learning and recall. Thus, NPS in the amygdala engages cellular processes that facilitate fear extinction through an action in addition to that on fear expression.
How might this dual effect of NPS be mediated? One likely route involves mobilization of intracellular Ca 2+ upon activation of NPS receptors (Reinscheid et al., 2005) . NPS receptors are located at glutamatergic synapses from LA principal neurons to mpara IN, and receptor activation results in an increase in glutamate release (as discussed above). The major projection site of mpara IN is the CeA (Royer et al., 1999; Likhtik et al., 2005) , and the increase in glutamatergic transmission to this population of GABAergic neurons will impose an additional inhibitory influence on the CeA, the major output station of the amygdala for fear expression of behavior. It is interesting to note that IPSCs in the CeA are almost exclusively carried by a 2 -subunit-containing GABA A receptors (Marowsky et al., 2004) . Given the importance of a 2 -subunit-containing GABA A receptors in anxiolysis (Rudolph et al., 2001) , an NPS-mediated increase in afferent activation of these GABAergic mechanisms via the mpara IN may help to explain the strong anxiolytic-like effect observed upon local injection of NPS in the present study. Importantly, NPS receptors are positively coupled to the cAMP/PKA system (Reinscheid et al., 2005) . A result of NPS receptor-activated cAMP/PKA is phosphorylation of MAPK (Reinscheid et al., 2005) , potentially giving rise to long-term effects involving nuclear regulation of protein synthesis. In fact, fear extinction is sensitive to modulation of kinase activity in the BLA complex, including the MAPK-ERK pathway (Lu et al., 2001; Herry et al., 2006) and requires de novo protein synthesis in the BLA (Yang and Lu, 2005) . NPS may thus represent a transmitter system supporting a link to these processes in principal neurons in the LA, thereby enabling a lasting increase in efficacy of synaptic connections to GABAergic mpapra IN and a modulation of fear extinction on a long-term scale. In line with this is the previous finding that synaptic longterm potentiation of BLA inputs to mpara IN involves presynaptic mechanisms (Royer and Paré , 2002) . Many neurons in the LA/ BLA remain CS responsive during extinction (Repa et al., 2001) and will mediate via NPS-potentiated transmission to mpara IN an increased inhibitory input to the CeA, thereby facilitating fear extinction on a long-term scale. Collectively, our findings imply that endogenous NPS has a dual function to acutely attenuate anxiety-like responses and later facilitate extinction of aversive memories. Such dual effects could be therapeutically beneficial to treat conditions like posttraumatic stress disorder or chronic anxiety disorders.
EXPERIMENTAL PROCEDURES
All experiments were carried out in accordance with the European Committees Council Directive (86/609/EEC) and US federal regulations and guidelines for experimentation on animals. Protocols were approved by the Bezirksregierung Mü nster (AZ 50.0835.1.0, G 53/2005 ) and the local Institutional Animal Care and Use Committee (IACUC) of the University of California, Irvine.
Behavioral Testing In Vivo
Mice (C57BL/6J; 8-12 weeks old) were implanted with a 26 gauge stainlesssteel guide cannula bilaterally in the LA/BLA (stereotaxic coordinates: 1.8 mm anterior, 3.7 mm lateral, and 3.2 mm dorsoventral from brain surface) under deep pentobarbital anesthesia (75 mg/kg i.p.). Animals were allowed to recover from surgery for at least 4 days. Local drug infusion was performed under anesthesia through forene inhalation (isofluran, 1-chloro-2,2,2-trifluoroethyl-difluoromethylether; induction: 2.5%, maintenance: 1.5%; in O 2 ; flow rate 1 l/min). Using a 10 ml Hamilton microliter syringe, the following solutions were infused with a 33 gauge beveled needle injector (0.1 ml/min, 0.5 ml each side): SHA 68 (10 mM, in 10% Cremophor-PBS buffer), NPS (10 mM), and, as vehicle controls, saline, 10% Cremophor-PBS buffer. Drugs were applied (1) at different times (20 min, 2 hr, 4 hr) before tests of general anxiety, (2) before (20 min) or after (1 hr) fear conditioning, and (3) at different times before (20 min, 2 hr) retrieval 1 as well as immediately after retrieval 6 (Supplemental Data and Figure S2 ). One individual animal underwent only one type of test of general anxiety or underwent the fear training/retrieval protocol, only one substance was tested in an individual animal, drug effects were compared with vehicle controls using the same injection protocols, and the behavioral testing was performed by the experimenter blind to pharmacological treatment of mice. At the end of the experiments, locations of the infusion cannula were histologically verified in frozen frontal sections of 40 mm, stained with cresyl violet. Furthermore in individual animals (n = 9), the diffusion of NPS solution was verified using microinjection of Cy3-NPS (Phoenix Pharmaceuticals, Inc., Belmont, USA) and verification of injection/diffusion sites in 30 mm coronal cryosections under a fluorescent microscope, followed by histological verification through cresyl violet ( Figure S1 ). General anxiety was tested using the open field test, plus maze test, and dark-light test (Supplemental Data). Fear conditioning was performed using a fear training apparatus (TSE, Bad Homburg, Germany). On day 1, animals were adapted through two presentations of six CSÀ (2.5 kHz tone, 85 dB, stimulus duration 10 s, interstimulus interval 20 s; intertrial interval 6 hr). On the next day, fear conditioning was performed through two exposures of three randomly presented CS+ (10 kHz tone, 85 dB, stimulus duration 10 s, randomized interstimulus interval 10-30 s; intertrial interval 6 hr), each of which was coterminated with a US (scrambled foot shock of 0.4 mA, duration 1 s). Twenty-four hours later (day 3), single animals were transferred to the retrieval environment (novel context) and habituated over a period of 30 min, before being exposed to six retrieval sessions (R1-R6) for extinction training (intertrial interval 30 min), each consisting of a set of four CSÀ and (40 s later) a set of four CS+ (stimulus duration 10 s, interstimulus interval 20 s). After 24 hr (day 4), recall of extinction was tested by exposing the animal to one set of 4 CSÀ and 40 s later to a set of 4 CS+ (stimulus duration 10 s, interstimulus interval 20 s). Extinction recall was tested twice (E1, E2; interval 30 min). For renewal of extinct fear (RN), mice were returned to the initial shock context and received a set of 4 CSÀ and 40 s later a set of 4 CS+. The conditioning protocol is illustrated in Figure S2 .
Analysis of Behavioral Data
For offline evaluation of conditioned freezing behavior (immobilization except for respiratory movements), a time line version of Wintrack was used (see Laxmi et al., 2003) . Freezing time was calculated as percentage during total CS+ presentations within a recording session (R1 to R6, E1, E2, RN). Data are presented as mean with standard error of the mean (±SEM). Mann-Whitney U test or Wilcoxon test were used, as applicable.
In Situ Hybridization for NPS Receptors A rat NPSR probe was used to hybridize coronal mouse brain sections at low stringency. Procedures and materials were essentially as described before (Xu et al., 2007) . For the final stringent wash, sections were incubated for 30 min in 0.3 3 SSC/1 mM DTT at 60 C.
Electrophysiological Recordings in Amygdala Slices
In Vitro GAD67-EGFP mice (P15-P26 or P47-P56) were anesthetized with forene (isofluran, 1-chloro-2,2,2-trifluoroethyl-difluoromethylether) and killed by decapitation. Coronal slices containing the amygdala were prepared and whole-cell patch-clamp recordings were performed as described previously (Supplemental Data; Szinyei et al., 2000 Szinyei et al., , 2003 . Specifically, neurons were approached under visual control by differential interference contrast infrared videomicroscopy (B/W-camera CF8/1, Kappa, Gleichen, Germany). EGFP-GAD67-expressing neurons were identified by fluorescent microscopy (Axioskop 2 FS plus, Zeiss, Germany). Neurons with resting membrane potential positive to À60 mV were rejected from analysis. Extracellular stimuli (100 ms duration, 200 to 600 mA) were delivered through a bipolar stainless-steel electrode placed in the LA or external capsule (Szinyei et al., 2000 (Szinyei et al., , 2003 . Picrotoxin (100 mM), CGP55845 (10 mM), and D-(-)-2-amino-5-phosphonopentanoic acid (AP5, 50 mM) or 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 mM) and AP5 (50 mM) were added to the bathing solution as required to isolate AMPA or GABA A receptor-mediated current components (toxins purchased from Tocris Cookson Ltd). NPS stock solution (NPS in phosphate-buffered saline and 0.1% bovine serum albumin) was diluted to a concentration of 1 mM and bath applied (final concentration of 10 mM; for dose-response see Figure S6 ). The NPS receptor antagonist SHA 68 was solved in dimethyl sulfoxide (DMSO) and was applied at a final concentration of 100 mM prior to addition of NPS (final concentration of DMSO <0.2%). Glutamate (200 mM, Biotrend) was locally applied in close vicinity (15-20 mm) of a recorded cell in small volumes ($10-50 pl, eight times at 5 min intervals) using pressure pulses (Picospritzer II, General Valve Corporation, New Jersey, USA).
Analysis of In Vitro Data
Effects of NPS on postsynaptic currents (PSCs) were analyzed as follows. After baseline stabilization, PSCs were recorded upon alternating stimulation at 0.05 Hz. Amplitudes of evoked EPSCs were calculated and averaged from 15 consecutive EPSCs during baseline conditions (before application of NPS) and 15 consecutive EPSCs during near-maximal action of NPS from original current traces in a given neuron. Obtained values were averaged from different neurons and are presented as mean amplitude (in pA) under baseline conditions and in the presence of NPS. Normalized mean amplitudes were obtained from two lines of experiments. First, EPSC amplitudes obtained during action of NPS were normalized with respect to baseline EPSCs in individual neurons, and averaging the normalized values from different neurons yielded NPS responses in percent baseline. Second, in a group of control cells (without application of NPS), EPSCs were monitored over the same time course as for NPS experiments, amplitudes at time points matching maximal NPS action were normalized with respect to baseline EPSCs, and averaging the normalized values from different neurons yielded control responses in percent baseline. Data for washout were obtained following the same procedures, but at time points after decline of NPS action. For analyses of putative monosynaptic responses, signals smaller than two times the standard deviation of baseline noise were declared as failures and were excluded. Paired-pulse experiments consisted of two consecutive stimuli with an interval of 100 ms. Traces containing failures produced by at least one of the two stimuli were rejected from analysis. The paired-pulse ratio was calculated (Amplitude EPSC2 / Amplitude EPSC1 ) during baseline stimulation and in presence of NPS. Miniature EPSCs were recorded over a time period of 150 s (100 traces with 1.5 s duration at a sampling rate of 5 kHz) to determine control amplitudes and frequencies of glutamate receptor-mediated currents. Twenty-five minutes after NPS application, recordings of mEPSCs were repeated. Data sets were imported to ''MiniAnalysis'' (Synaptosoft Inc., Decatur, GA, USA), and amplitudes and frequencies prior and post NPS application were identified. Mean frequencies and amplitudes of individual recordings were averaged and tested for significance. Data are presented as means with standard error of the mean (±SEM). For statistical comparison, ANOVA or Student's t test were used, as applicable.
Cell-Type-Specific Quantitative Real-Time RT-PCR After establishing whole-cell configuration with the patched neuron, in some cases after recording (5 min), the cell was lifted above the slice, the cell content was sucked into the pipette and transferred into 3 ml carrier RNA buffer (RNeasy Micro Kit, QIAGEN) by breaking the tip of the pipette and expelling $3 ml of solution with positive pressure. The pipette solution (6 ml) was supplemented with a recombinant ribonuclease inhibitor (0.24 U/ml; RNasin; Promega, Madison, WI, USA). Cytoplasm from single, identified cells were pooled (lpara IN: two groups of 20 and 21 pooled cells; mpara IN: 21 pooled cells; LA PN: three groups of pooled cells: 12, 17, 16, respectively), and the RNA was isolated without DNase treatment (all primers designed to be intronspanning) using an RNA isolation kit (RNeasy Micro Kit, QIAGEN). Reverse transcription (RT) protocol was used in cDNA preparation from isolated RNA (Sosulina et al., 2006) and subsequently preamplified as modified from Allison et al. (2006) . A single-plex PCR (20 cycles) was performed (denaturation at 94 C, 25 s; annealing at 51 C, 2 min for the first five cycles, and 45 s for the remaining cycles; extension at 72 C, 60 s; final elongation at 72 C, 7 min) for hypoxanthine-guanine phosphoribosyltransferase (Hprt1, reference gene; Chen et al., 2001 ) and neuropeptide S receptor 1 (Npsr1). Relative quantitative real-time PCR was performed on preamplified cDNA using FAM-labeled detection assays (TaqMan, Applied Biosystems) for the Npsr1 and Hprt1 in conjunction with the Real Master Mix (5Prime) in an ABI Prism 7000 Sequence Detection System (Applied Biosystems; 50 cycles of 15 s at 95 C and 1 min at 60 C preceded by a 2 min decontamination step at 50 C and 10 min denaturation step at 95 C). Primer sequences are specified in Supplemental Data.
Transcript levels of the Npsr1 were normalized to Hprt1 using the equation 2 -DC(t) , where C(t) is the mean cycle threshold level and DC(t) = (C(t) Npsr1) À (C(t) Hprt1) (Livak and Schmittgen, 2001 ).
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and figures and can be found with this article online at http://www.neuron.org/ cgi/content/full/59/2/298/DC1/.
